Search

everythinglearnresearchcommunity

for

Search:↓

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

People with Alopecia areata often have lower vitamin D levels, which may be linked to the severity of their condition.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

PRP treatment may help with alopecia areata, especially in newer cases.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

AB+ blood group is more common in alopecia areata patients.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Higher CRBP1 levels are linked to more severe alopecia areata.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.